Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction. A randomized, placebo-controlled, double-blind study (RUSSLAN) - Moiseyev, V S; Poder, P; Andrejevs, N (Eur Heart J, 2002)